Company Details
Sector | PHARMACEUTICALS |
Address | One IBL Centre 2nd Floor Plot # 1 Block 7 & 8 D.M.C.H.S Tipu Sultan Road Off Shahrah-e-Faisal Karachi |
Auditor | A. F. Ferguson & Co. Chartered Accountants |
Registrar | CDC Share Registrar Services Limited, CDC House, 99-B , Block B S.M.C.H.S Main Shahrah-e-Faisal, Karachi |
Website | www.searlecompany.com |
Fiscal Year | June |
Details |
Details
The Searle Company Limited was incorporated in Pakistan as a private limited company in October 1965. In November 1993@ the Company was converted into a public limited company under the repealed Companies Ordinance@ 1984 (now Companies Act@ 2017). The Company is principally engaged in the manufacture of pharmaceutical and other consumer products. International Brands (Private) Limited is the Parent Company@ which holds 56.32% shareholding in the Company.
Company Announcements
Date/Time | Announcement |
---|---|
28/09/2023 15:22:31 | FINANCIAL RESULT FOR THE YEAR ENDED 30/06/2023 (CONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,144.124 (CONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 413.053 EPS = 0.80 |
28/09/2023 15:21:51 | EPS = 0.77 ANNUAL GENERAL MEETING HELD ON 27/10/2023 BOOK CLOSURE FROM 21/10/2023 FINANCIAL RESULT FOR THE YEAR ENDED 30/06/2023 BOOK CLOSURE TO 27/10/2023 (UNCONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 409.835 (UNCONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 302.137 |
08/08/2023 14:36:54 | FOR THE YEAR ENDED 30/06/2023 BOOK CLOSURE FROM 21/08/2023 BOOK CLOSURE TO 25/08/2023 RIGHT ISSUE = 31.13 AT A PREMIUM OF Rs.25/= PER SHARE |
25/05/2023 15:46:56 | RIGHT ISSUE = 31.13 AT A PREMIUM OF Rs.25/= PER SHARE FOR THE YEAR ENDED 2023 |
28/04/2023 16:35:28 | FINANCIAL RESULT FOR THE NINE MONTHS ENDED 31/03/2023 (CONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 943.477 (CONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,538.388 EPS = 2.14 |